| Literature DB >> 16709834 |
Francesca Fallarino1, Ursula Grohmann, Sylvaine You, Barbara C McGrath, Douglas R Cavener, Carmine Vacca, Ciriana Orabona, Roberta Bianchi, Maria L Belladonna, Claudia Volpi, Pere Santamaria, Maria C Fioretti, Paolo Puccetti.
Abstract
Tryptophan catabolism is a tolerogenic effector system in regulatory T cell function, yet the general mechanisms whereby tryptophan catabolism affects T cell responses remain unclear. We provide evidence that the short-term, combined effects of tryptophan deprivation and tryptophan catabolites result in GCN2 kinase-dependent down-regulation of the TCR zeta-chain in murine CD8+ T cells. TCR zeta down-regulation can be demonstrated in vivo and is associated with an impaired cytotoxic effector function in vitro. The longer-term effects of tryptophan catabolism include the emergence of a regulatory phenotype in naive CD4+CD25- T cells via TGF-beta induction of the forkhead transcription factor Foxp3. Such converted cells appear to be CD25+, CD69-, CD45RBlow, CD62L+, CTLA-4+, BTLAlow and GITR+, and are capable of effective control of diabetogenic T cells when transferred in vivo. Thus, both tryptophan starvation and tryptophan catabolites contribute to establishing a regulatory environment affecting CD8+ as well as CD4+ T cell function, and not only is tryptophan catabolism an effector mechanism of tolerance, but it also results in GCN2-dependent generation of autoimmune-preventive regulatory T cells.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16709834 DOI: 10.4049/jimmunol.176.11.6752
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422